Drug Profile
Research programme: parathyroid hormone analogues - Chugai
Alternative Names: SP-PTHLatest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Chugai Pharmaceutical
- Class Peptide hormones
- Mechanism of Action Parathyroid hormone receptor type 1 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hypoparathyroidism
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for preclinical development in Hypoparathyroidism in Japan (SC, Injection)
- 16 Sep 2016 Pharmacodynamics data from a preclinical trial presented at the 38th Annual Meeting of the American Society for Bone and Mineral Research (ASBMR-2016)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Hypoparathyroidism in Japan (SC, Injection)